価格表

在庫・価格 : 2025年11月03日 13時53分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human LDL R MAb (Clone 472413)
データシート※最新のデータシートでない場合があります
MAB2148-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000 1個 追加

在庫・価格 : 2025年11月03日 13時53分 現在

Anti-Human LDL R MAb (Clone 472413)

  • 商品コード:MAB2148-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Masuda Y et al. Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein. J Pharmacol Exp Ther 2018 05;365(2):368-37
Masuda Y et al
2018/01/01
Species: Human, Applications: ELISA Capture PubMed
2 Poirier S et al. Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route. J. Biol. Chem. 2009 Oct;284(42):28856-64
Poirier S et al
2009/01/01
Species: Human, Applications: Western Blot PubMed
3 Karta MR et al. Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages. J. Allergy Clin. Immunol. 2014 Apr;133(4):1227-30
Karta MR et al
2014/01/01
Species: Human, Applications: Flow Cytometry PubMed
4 DeVay RM et al. Characterization of proprotein convertase subtilisin/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like protein 2 (APLP2). J. Biol. Chem. 2013 Apr;288(15):10805-18
DeVay RM et al
2013/01/01
Species: Human, Applications: ELISA Development PubMed
5 Amirache F et al. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood 2014 Feb;123(9):1422-4
Amirache F et al
2014/01/01
Species: Human, Applications: Flow Cytometry PubMed
6 Boucrot E et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature 2015 Jan;517(7535):460-5
Boucrot E et al
2015/01/01
Applications: Functional Assay PubMed
7 Susan-Resiga D et al. The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA. J. Biol. Chem. 2017 02;292(5):1573-1590
Susan-Resiga D et al
2017/01/01
Species: Human, Applications: Flow Cytometry PubMed
8 Weider E et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation. J. Biol. Chem. 2016 Aug;291(32):16659-71
Weider E et al
2016/01/01
Species: Human, Applications: IHC PubMed
  • No.: 1
  • 文献情報:
    Masuda Y et al. Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein. J Pharmacol Exp Ther 2018 05;365(2):368-37
    Masuda Y et al
    2018/01/01
  • 備考:
    Species: Human, Applications: ELISA Capture
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Poirier S et al. Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route. J. Biol. Chem. 2009 Oct;284(42):28856-64
    Poirier S et al
    2009/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Karta MR et al. Allergen challenge in vivo alters rhinovirus-induced chemokine secretion from human airway macrophages. J. Allergy Clin. Immunol. 2014 Apr;133(4):1227-30
    Karta MR et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    DeVay RM et al. Characterization of proprotein convertase subtilisin/kexin type 9 (PCSK9) trafficking reveals a novel lysosomal targeting mechanism via amyloid precursor-like protein 2 (APLP2). J. Biol. Chem. 2013 Apr;288(15):10805-18
    DeVay RM et al
    2013/01/01
  • 備考:
    Species: Human, Applications: ELISA Development
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Amirache F et al. Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor. Blood 2014 Feb;123(9):1422-4
    Amirache F et al
    2014/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Boucrot E et al. Endophilin marks and controls a clathrin-independent endocytic pathway. Nature 2015 Jan;517(7535):460-5
    Boucrot E et al
    2015/01/01
  • 備考:
    Applications: Functional Assay
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Susan-Resiga D et al. The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIA. J. Biol. Chem. 2017 02;292(5):1573-1590
    Susan-Resiga D et al
    2017/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Weider E et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation. J. Biol. Chem. 2016 Aug;291(32):16659-71
    Weider E et al
    2016/01/01
  • 備考:
    Species: Human, Applications: IHC
  • 参照:
    PubMed